ENTITY
Exelixis Inc

Exelixis Inc (EXEL US)

23
Analysis
Health CareUnited States
Exelixis, Inc. is a development-stage biotechnology company dedicated to the discovery and development of small-molecule therapeutics for the treatment of cancer and other serious diseases. The Company is building a portfolio of compounds it believes could become pharmaceutical products. Exelixis has strategic alliances with pharmaceutical and biotechnology companies.
more
Company Event11 Dec 2025 02:00 • Upcoming
Add To Calendar
Company Event11 Feb 2026 13:00 • Upcoming
Add To Calendar
Company Event11 Nov 2025 21:40 • Upcoming
Add To Calendar
Company Event10 Nov 2025 23:30 • Latest
Company Event05 Nov 2025 06:00
x